Biogena Group Invest Ag (BIO.VI)

EUR 1.54

(0.0%)

Annual Income Statements

(In EUR)
Breakdown 2024 2023 2022 2021
Revenue 166.05 Thousand 251.05 Thousand 331.05 Thousand 329.3 Thousand
Cost of Revenue 900.00 720.00 820.00 -
Gross Profit 165.15 Thousand 250.33 Thousand 330.23 Thousand 329.3 Thousand
Operating Expenses 161.72 Thousand 156.54 Thousand 404.96 Thousand 288.46 Thousand
Selling, General and Administrative Expenses 36.77 Thousand 32.63 Thousand 247.89 Thousand 124.74 Thousand
Research and Development Expenses - - - -
Other Expenses 124.94 Thousand - - -
Cost and Expenses 162.62 Thousand 157.26 Thousand 405.78 Thousand 288.46 Thousand
Operating Income 3433.77 93.15 Thousand -75.84 Thousand 39.89 Thousand
Interest Expense 180.38 1.22 2.63 -
Income Tax Expense 3498.16 3522.88 81.43 Thousand 34.29 Thousand
Earnings before Tax 175.9 Thousand 301.71 Thousand 816.69 Thousand 150.94 Thousand
Net Income 172.4 Thousand 298.19 Thousand 735.25 Thousand 116.65 Thousand
Earnings Per Share Basic - 0.07 0.18 0.06
Earnings Per Share Diluted - 0.07 0.18 0.06
Weighted Average Shares Outstanding - - 3.99 Million 1.99 Million
Weighted Average Shares Outstanding (Diluted) - - 3.99 Million 1.99 Million
Gross Margin 0.99 1.00 1.00 1.00
EBIT Margin 1.06 1.20 2.47 0.46
Profit Margin 1.04 1.19 2.22 0.35
EBITDA 176.08 Thousand 301.71 Thousand 816.69 Thousand 150.94 Thousand
Earnings Before Tax Margin 0.02 0.37 -0.23 0.12

Income Statement Charts